A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis
Authors:
- 1 January 2016
- journal article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 116 (2) , 63
Abstract
To compare the results of treatment of multiple sclerosis (MS) with genfaxon, cinnovex and rebif.Keywords
This publication has 3 references indexed in Scilit:
- Algorithms of using valproic acid drugs in womenS.S. Korsakov Journal of Neurology and Psychiatry, 2015
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patientsMultiple Sclerosis Journal, 1995